Literature DB >> 11849867

Pressure overload hypertrophy and congestive heart failure. Where is the "Achilles' heel"?

Kirk L Peterson.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11849867     DOI： 10.1016/s0735-1097(01)01790-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  11 in total

1.  Chronic Ethanol Administration Prevents Compensatory Cardiac Hypertrophy in Pressure Overload.

Authors:  Van K Ninh; Elia C El Hajj; Alan J Mouton; Milad C El Hajj; Nicholas W Gilpin; Jason D Gardner
Journal:  Alcohol Clin Exp Res       Date:  2018-05-30       Impact factor: 3.455

2.  High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.

Authors:  Muhammad Hammadah; Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Malory Weber; Yuping Wu; Stanley L Hazen; Javed Butler; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2017-02-07       Impact factor: 15.534

Review 3.  A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.

Authors:  Jihong Yang; Yufeng Liu; Xiaohui Fan; Zheng Li; Yiyu Cheng
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

4.  LRRC10 is required to maintain cardiac function in response to pressure overload.

Authors:  Matthew J Brody; Li Feng; Adrian C Grimes; Timothy A Hacker; Timothy M Olson; Timothy J Kamp; Ravi C Balijepalli; Youngsook Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-25       Impact factor: 4.733

5.  Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

Authors:  Edward T Ha; Marc Cohen; Stephen J Peterson; Wilbert S Aronow
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-04-09

Review 6.  Characterizing heart failure in the ventricular volume domain.

Authors:  Peter Lm Kerkhof
Journal:  Clin Med Insights Cardiol       Date:  2015-02-25

Review 7.  The case for inhibiting p38 mitogen-activated protein kinase in heart failure.

Authors:  Pelin Arabacilar; Michael Marber
Journal:  Front Pharmacol       Date:  2015-05-12       Impact factor: 5.810

Review 8.  Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome.

Authors:  Mohamed Asrih; François Mach; Alessio Nencioni; Franco Dallegri; Alessandra Quercioli; Fabrizio Montecucco
Journal:  Mediators Inflamm       Date:  2013-01-09       Impact factor: 4.711

9.  S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice.

Authors:  Xiao M Pei; Bjorn T Tam; Thomas K Sin; Feng F Wang; Benjamin Y Yung; Lawrence W Chan; Cesar S Wong; Michael Ying; Christopher W Lai; Parco M Siu
Journal:  Front Physiol       Date:  2016-08-05       Impact factor: 4.566

10.  MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload.

Authors:  Yue Ji; Ming Qiu; Yejiao Shen; Li Gao; Yaqing Wang; Wei Sun; Xinli Li; Yan Lu; Xiangqing Kong
Journal:  Int J Mol Med       Date:  2018-01-25       Impact factor: 4.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.